Clinical Pharmacological Aspects of Valproate Sodium

EFFECTS OF DI‐n‐PROPYLACETATE, AN ANTICONVULSIVE COMPOUND, ON GABA METABOLISM¹

1969 • 394 citations

Effect of sodium n-dipropylacetate on audiogenic seizures and brain γ-aminobutyric acid level

1973 • 285 citations

Pharmacokinetics of di-n-propylacetate in epileptic patients

1975 • 142 citations

Effects of Anticonvulsant Drugs on the Cerebral Enzymes Metabolizing GABA

1975 • 105 citations

Valproate Sodium: A Controlled Clinical Trial Including Monitoring of Drug Levels

1977 • 96 citations

Concentration of Dipropylacetate in Plasma

1975 • 87 citations

Metabolism of branched medium chain length fatty acid. II—β-oxidation of sodium dipropylacetate in rats

1976 • 66 citations

Determination of lower fatty acids, particularly the anti-epileptic dipropyl-acetic acid, in biological materials by means of micro diffusion and gas chromatography

1973 • 61 citations

Absorption and Distribution of Antiepileptic Drugs

1975 • 57 citations

Metabolism of branched medium chain length fatty acid: I—ω-oxidation of sodium dipropylacetate in rats

1974 • 41 citations

[Rapid method of quantitative analysis of sodium dipropylacetate in serum or plasma].

1973 • 17 citations

Clinical Pharmacokinetics in Monitoring Chronic Medication with Anti-Epileptic Drugs

1975 • 16 citations

Etude des relations entre la structure cristalline et l'activite biologique de molecules des series di- et trialcoyl acetiques

1974 • 11 citations

Enteric Coated Dipropylacetate (Depakine®)

1975 • 8 citations